Cargando...
Icatibant and ACE inhibitor angioedema
Icatibant is a selective bradykinin 2 receptor antagonist, currently licensed for use in hereditary angioedema. Its benefit in ACE inhibitor angioedema is yet to be fully established. A handful of preliminary case reports suggest that it may be of benefit in reducing both symptom severity and possib...
Guardado en:
| Publicado en: | BMJ Case Rep |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMJ Group
2012
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4543926/ https://ncbi.nlm.nih.gov/pubmed/22936825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2012-006646 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|